Pigment retinopathy in warmblood horses with equine degenerative myeloencephalopathy and equine motor neuron disease.
- Journal Article
- Ataxia
- Clinical Examination
- Clinical Findings
- Clinical Pathology
- Clinical Signs
- Clinical Study
- Disease Diagnosis
- Disease Etiology
- Disease Management
- Disease Outbreaks
- Disease Prevention
- Disease Surveillance
- Disease Treatment
- Equine Diseases
- Equine Motor Neuron Disease
- Genetics
- Horse Breeds
- Horses
- Neurological Diseases
- Neurology
- Ophthalmology
- Pathophysiology
- Post Mortem
- Retina
- Veterinary Care
- Veterinary Medicine
- Veterinary Research
- Vitamin E
- Warmblood Horses
Summary
The research is mainly focused on the occurrence of a pigment retinopathy in horses with equine motor neuron disease (EMND) and neuroaxonal dystrophy/equine degenerative myeloencephalopathy (NAD/EDM), which are conditions both linked to α-tocopherol (α-TP) deficiency. This is particularly relevant for Warmblood breed horses that have genetically predisposed susceptibilities.
Objective of the Research
The main aim of this study was to describe a pigment retinopathy, a condition not previously identified in horses with α-TP deficiency and subsequent NAD/EDM or EMND. This observation is primarily noted in a family of Warmblood horses. The research endeavored to bring to light new findings in the field of veterinary neuroscience and opthalmic health.
The Process
- Twenty-five Warmblood horses from a single farm were selected for the study.
- These horses underwent complete neurologic, as well as ophthalmic examinations. Serum α-TP concentrations in these horses were also evaluated.
- Two of the horses exhibiting the most significant ataxic symptoms were euthanized and postmortem examinations were conducted.
Findings
- The research found a prevalent α-TP deficiency among the horses in the tested farm with this showing up in 22 out of 25 horses.
- Out of the 25 horses, 11 horses did not display any clinical abnormalities, one showed signs of EMND, while 10 exhibited signs of ataxia, a condition related to NAD/EDM.
- It was established that two horses had both NAD/EDM and EMND, a finding that was post-mortem confirmed.
- Fundamentally, the research uncovered a pigment retinopathy in 5 horses. This was detected through the appearance of granular dark pigment in the tapetal retina of the horses’ eyes, which were either clinical manifestations of NAD/EDM. One horse surprisingly exhibited this as a sign of EMND.
Conclusion
The research concludes that a pigment retinopathy can be a symptom in young horses that display clinical signs of both EMND and NAD/EDM, and are deficient in α-TP. This emerging evidence is significantly relevant for the Warmblood breed, and warrants further investigation.
Cite This Article
Publication
Researcher Affiliations
- Population Health and Reproduction, School of Veterinary Medicine, School of Medicine, University of California, Davis, CA, 95616, USA.
- Eye Care for Animals, Lees Summit, MO, 64064, USA.
- Section of Anatomic Pathology, Department of Biomedical Sciences Medicine, Cornell University College of Veterinary, Ithaca, NY, 14853, USA.
- Population Health and Reproduction, School of Veterinary Medicine, School of Medicine, University of California, Davis, CA, 95616, USA.
- Department of Clinical Sciences, Cornell University College of Veterinary Medicine, Ithaca, NY, 14853, USA.
- Large Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI, 48895, USA.
MeSH Terms
- Animals
- Brain Diseases / diagnosis
- Brain Diseases / veterinary
- Female
- Horse Diseases / diagnosis
- Horse Diseases / pathology
- Horses
- Male
- Motor Neuron Disease / diagnosis
- Motor Neuron Disease / pathology
- Motor Neuron Disease / veterinary
- Neurologic Examination / veterinary
- Pedigree
- Pigments, Biological
- Retinal Diseases / diagnosis
- Retinal Diseases / pathology
- Retinal Diseases / veterinary
- Vitamin E Deficiency / diagnosis
- Vitamin E Deficiency / pathology
- Vitamin E Deficiency / veterinary
- alpha-Tocopherol / blood
Grant Funding
- K01 OD015134 / NIH HHS
- L40 TR001136 / NCATS NIH HHS
References
- Schneider C. Chemistry and biology of vitamin E. Molecular Nutrition & Food Research 2005;49:7–30.
- Finno CJ, Valberg SJ. A comparative review of vitamin E and associated equine disorders. Journal of Veterinary Internal Medicine 2012;26:1251–1266.
- Yokota T, Igarashi K, Uchihara T. Delayed-onset ataxia in mice lacking alpha-tocopherol transfer protein: model for neuronal degeneration caused by chronic oxidative stress. Proceedings of the National Academy of Sciences of the United States of America 2001;98:15185–15190.
- Hayes KC. Pathophysiology of vitamin E deficiency in monkeys. The American Journal of Clinical Nutrition 1974;27:1130–1140.
- Riis RC, Sheffy BE, Loew E. Vitamin E deficiency retinopathy in dogs. American Journal of Veterinary Research 1981;42:74–86.
- McLellan GJ, Cappello R, Mayhew IG. Clinical and pathological observations in English cocker spaniels with primary metabolic vitamin E deficiency and retinal pigment epithelial dystrophy. The Veterinary Record 2003;153:287–292.
- Davidson MG, Geoly FJ, Gilger BC. Retinal degeneration associated with vitamin E deficiency in hunting dogs. Journal of the American Veterinary Medical Association 1998;213:645–651.
- Yokota T, Shiojiri T, Gotoda T. Retinitis pigmentosa and ataxia caused by a mutation in the gene for the alpha-tocopherol-transfer protein. The New England Journal of Medicine 1996;335:1770–1771.
- Riis RC, Jackson C, Rebhun W. Ocular manifestations of equine motor neuron disease. Equine Veterinary Journal 1999;31:99–110.
- Muller DP. Vitamin E and neurological function. Molecular Nutrition & Food Research 2010;54:710–718.
- Aleman M, Finno CJ, Higgins RJ. Evaluation of epidemiological, clinical, and pathological features of neuroaxonal dystrophy in Quarter Horses. Journal of the American Veterinary Medical Association 2011;239:823–833.
- Finno CJ, Higgins RJ, Aleman M. Equine degenerative myeloencephalopathy in Lusitano horses. Journal of Veterinary Internal Medicine 2011;25:1439–1446.
- Finno CJ, Estell K, Katzman S. Blood and cerebrospinal fluid alpha-tocopherol and selenium concentrations in neonatal foals with neuroaxonal dystrophy. Journal of Veterinary Internal Medicine 2015;29:1667–1675.
- Mohammed HO, Divers TJ, Summers BA. Vitamin E deficiency and risk of equine motor neuron disease. Acta Veterinaria Scandinavica 2007;49:17.
- Finno CJ, Aleman M, Ofri R. Electrophysiological studies in American Quarter horses with neuroaxonal dystrophy. Veterinary Ophthalmology 2012;15(Suppl 2):3–7.
- Garbe JR, Da Y. Pedigraph: A Software Tool for the Graphing and Analysis of Large Complex Pedigrees. User Manual Version 2.4. .
- Divers TJ, De Lahunta A, Hintz HF. Equine motor neuron disease. Equine Veterinary Education 2001;13:63–67.
- Finno CJ, Famula T, Aleman M. Pedigree analysis and exclusion of alpha-tocopherol transfer protein (TTPA) as a candidate gene for neuroaxonal dystrophy in the American Quarter Horse. Journal of Veterinary Internal Medicine 2013;27:177–185.
- Finno CJ, Aleman M, Higgins RJ. Risk of false positive genetic associations in complex traits with underlying population structure: a case study. Veterinary Journal 2014;202:543–549.
- Cummings JF, de Lahunta A, George C. Equine motor neuron disease; a preliminary report. The Cornell Veterinarian 1990;80:357–379.
- Stone WL, Farnsworth CC, Dratz EA. A reinvestigation of the fatty acid content of bovine, rat and frog retinal rod outer segments. Experimental Eye Research 1979;28:387–397.
- Finno CJ, Miller AD, Siso S. Concurrent equine degenerative myeloencephalopathy and equine motor neuron disease in three young horses. Journal of Veterinary Internal Medicine 2016;30:1344–50. In Press.
- Bedford HE, Valberg SJ, Firshman AM. Histopathologic findings in the sacrocaudalis dorsalis medialis muscle of horses with vitamin E-responsive muscle atrophy and weakness. Journal of the American Veterinary Medical Association 2013;242:1127–1137.